Cancer Chemotherapy and Pharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 42.7% | 0.851 | Q2 | 79.3% |
| 2024 | 2.3 | Q3 | 43.1% | 0.969 | Q1 | 83.4% |
| 2023 | 2.7 | Q2 | 54.1% | 0.869 | Q1 | 82.1% |
| 2022 | 3.0 | Q3 | 53.3% | 0.811 | Q1 | 80.9% |
| 2021 | 3.3 | Q3 | 55.4% | 0.848 | Q1 | 82.7% |
| 2020 | — | — | 1.112 | Q1 | 87.5% | |
| 2019 | — | — | 1.239 | Q1 | 89.8% | |
| 2018 | — | — | 1.199 | Q1 | 87.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0344-5704
ISSN
1432-0843
country
DEcoverage
1978-2026